Zobrazeno 1 - 10
of 89
pro vyhledávání: '"Michael Eaddy"'
Autor:
Maria Dall’Era, Kenneth Kalunian, Michael Eaddy, Augustina Ogbonnaya, Eileen Farrelly, Eric Turowski, Vanessa Birardi, Neil Solomons, Simrat Randhawa, Paola Mina-Osorio
Publikováno v:
Journal of managed carespecialty pharmacy. 29(1)
Publikováno v:
Journal of Medical Economics. 22:1030-1040
Aims: Electroencephalography (EEG) is an established method to evaluate and manage epilepsy; video EEG (VEEG) has significantly improved its diagnostic value. This study compared healthcare...
Autor:
Yaping Shou, Jill A Bell, Michael Eaddy, Augustina Ogbonnaya, Aditya Raju, Aaron Galaznik, Kristin Hennenfent, Laurie Hamilton, Vicki A. Morrison
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 19:e172-e183
Background Few studies have evaluated real-world treatment patterns and survival in follicular lymphoma (FL). This study evaluated these outcomes among newly diagnosed patients with FL in routine clinical care. Patients and Methods A retrospective st
Autor:
Joshua M Noone, Michael Eaddy, Orsolya Lunacsek, Christopher M. Blanchette, E Zacherle, Jeffrey T. Guptill, M. Chris Runken, Rupali M Fuldeore
Publikováno v:
Patient preference and adherence
Jeffrey T Guptill,1 M Chris Runken,2 Michael Eaddy,3 Orsolya E Lunacsek,4 Rupali M Fuldeore,4 Christopher M Blanchette,5 Emily Zacherle,5 Joshua M Noone51Department of Neurology, Duke University, Durham, NC, USA; 2Grifols SSNA, Research Triangle Park
Autor:
Jill A Bell, Aditya Raju, Aaron Galaznik, Vicki A. Morrison, Augustina Ogbonnaya, Laurie Hamilton, Yaping Shou, Michael Eaddy, Kristin Hennenfent
Publikováno v:
Future Oncology. 15:1021-1034
Aim: To evaluate treatment patterns of diffuse large B-cell lymphoma (DLBCL). Patients & methods: First-line and relapsed/refractory treatment patterns and survival outcomes following first-line therapy in adult patients newly diagnosed with DLBCL we
Publikováno v:
Lung Cancer. 127:53-58
Objectives To evaluate treatment patterns, physician-assessed overall response rate (ORR), progression-free survival (PFS), and overall survival (OS) among third-line (3L)-plus small cell lung cancer (SCLC) patients. Materials and methods Retrospecti
Publikováno v:
Journal of Oncology Practice. 14:e729-e738
Purpose: Access to high-quality cancer care remains a challenge for many patients. One such barrier is the increasing cost of treatment. With recent shifts in cancer care delivery from community-based to hospital-based clinics, we examined whether th
Autor:
Thomas P. Lodise, Laura Liao, Monica Spilsbury-Cantalupo, Melissa McCart, Michael Eaddy, Amy Law
Publikováno v:
Respir Care
BACKGROUND: Ventilator-associated pneumonia (VAP) is one of the most common hospital-acquired infections in ICUs and is associated with significant morbidity and mortality. Gram-negative bacteria cause 55–85% of hospital-acquired pneumonia and are
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f3b054e45947a1df8736f60ab16e3e4e
https://europepmc.org/articles/PMC9994115/
https://europepmc.org/articles/PMC9994115/
Autor:
Michael Eaddy, Todd Williamson, Sari Hopson, Anneliese LaRose, Huai-Che Shih, Linnea Tennan Tennant, Jennifer Cameron, Jason Lott
Publikováno v:
Journal of drugs in dermatology : JDD. 19(3)
Objective To assess differences in patient-reported treatment side effects and concerns associated with azelaic acid 15% foam (AAF) vs metronidazole cream (MC) and metronidazole gel (MG). Methods This study used matching-adjusted indirect comparison
Publikováno v:
Open Access Rheumatology : Research and Reviews
Nancy Ho-Mahler,1 Beni Turner,2 Michael Eaddy,2 Mark L Hanke,1 Winnie W Nelson1 1Mallinckrodt Pharmaceuticals, Bedminster, NJ, USA; 2Xcenda, Palm Harbor, FL, USACorrespondence: Nancy Ho-MahlerMallinckrodt Pharmaceuticals, 1425 U.S. Route 206, Bedmins